Colleen Flesher, Co-CEO of Vimian’s MedTech segment Movora, steps down

Regulatory press release
Nov 15 2023

Colleen Flesher, Co-CEO of Vimian’s MedTech segment Movora, steps down

Colleen Flesher has decided to step down from the Vimian Group management team and the position as Co-CEO Movora, to pursue an opportunity outside Vimian in another industry. Guy Spörri, today Co-CEO Movora, will assume full responsibility for the business from 1 December 2023.

- I would like to thank Colleen who has played an important role in the integration and creation of ONE Movora, establishing a strong platform for future profitable growth. While we regret Colleen’s departure, we have a strong team in place under the lead of Guy Spörri ensuring continuity for Movora. I wish Colleen success in her next role, says Fredrik Ullman, CEO of Vimian Group.

- It has been a true privilege to work for a global leader in veterinary medtech together with an amazing team with genuine commitment to animal health and wellbeing, says Colleen Flesher, departing Co-CEO Movora.

Guy Spörri, Co-CEO Movora, assumes full responsibility for Movora from 1 December 2023.

About Vimian

Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market’s most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches over 15,000 veterinary clinics and 1,700 labs, sells to over 90 markets, has 1,000 employees and annual revenues of approximately EUR 280 million. For more information, please visit: www.vimian.com. FNCA Sweden AB is appointed the Company’s Certified Adviser.